SHR-5495

N/A

Report date: 2025/03/05 14:59:13

Base Information

Drug NameSHR-5495

Drug Alias NameSHR-5495

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesSuzhou Suncadia Biopharmaceuticals Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSuzhou Suncadia Biopharmaceuticals Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A